Modulation of Cellular Phosphatidylinositol Turnover by Exogenous Phosphatidylinositol.
Patent Application, Filed 13 Aug 87,
DEPARTMENT OF THE ARMY WASHINGTON DC
Pagination or Media Count:
A pharmaceutical composition consisting essentially of an opsonized-liposome containing at least one phospholipid component and cholesterol which are more strongly ingested by animal peritoneal macrophages than liposomes not coated with Con A.
- Anatomy and Physiology